HRP20080069T3 - Avian e. coli vaccine for the protection against colibacillosis - Google Patents

Avian e. coli vaccine for the protection against colibacillosis

Info

Publication number
HRP20080069T3
HRP20080069T3 HR20080069T HRP20080069T HRP20080069T3 HR P20080069 T3 HRP20080069 T3 HR P20080069T3 HR 20080069 T HR20080069 T HR 20080069T HR P20080069 T HRP20080069 T HR P20080069T HR P20080069 T3 HRP20080069 T3 HR P20080069T3
Authority
HR
Croatia
Prior art keywords
avian
protection against
coli vaccine
against colibacillosis
identification characteristics
Prior art date
Application number
HR20080069T
Other languages
English (en)
Croatian (hr)
Inventor
H. Fan Henry
Kumar Mahesh
Marcello La Ragione Roberto
John Woodward Martin
Original Assignee
Wyeth
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth filed Critical Wyeth
Publication of HRP20080069T3 publication Critical patent/HRP20080069T3/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/025Enterobacteriales, e.g. Enterobacter
    • A61K39/0258Escherichia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
HR20080069T 2003-05-14 2008-02-13 Avian e. coli vaccine for the protection against colibacillosis HRP20080069T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47047103P 2003-05-14 2003-05-14
PCT/US2004/014835 WO2004103402A1 (en) 2003-05-14 2004-05-12 Avian e. coli vaccine for the protection against colibacillosis

Publications (1)

Publication Number Publication Date
HRP20080069T3 true HRP20080069T3 (en) 2008-03-31

Family

ID=33476714

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20080069T HRP20080069T3 (en) 2003-05-14 2008-02-13 Avian e. coli vaccine for the protection against colibacillosis

Country Status (28)

Country Link
US (2) US7357935B2 (xx)
EP (1) EP1622642B1 (xx)
JP (2) JP5334029B2 (xx)
KR (1) KR101106024B1 (xx)
CN (1) CN100387299C (xx)
AR (1) AR044338A1 (xx)
AT (1) ATE380557T1 (xx)
AU (1) AU2004240584B2 (xx)
BE (1) BE2012C053I2 (xx)
BR (1) BRPI0410332B1 (xx)
CA (1) CA2524942C (xx)
CO (1) CO5640040A2 (xx)
CY (1) CY1107188T1 (xx)
DE (1) DE602004010643T2 (xx)
DK (1) DK1622642T3 (xx)
ES (1) ES2297448T3 (xx)
FR (1) FR12C0073I2 (xx)
HK (1) HK1083597A1 (xx)
HR (1) HRP20080069T3 (xx)
HU (1) HUS1200029I1 (xx)
MX (1) MXPA05012218A (xx)
NZ (1) NZ543559A (xx)
PL (1) PL1622642T3 (xx)
PT (1) PT1622642E (xx)
SI (1) SI1622642T1 (xx)
TW (1) TW200505475A (xx)
WO (1) WO2004103402A1 (xx)
ZA (1) ZA200509979B (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7297338B2 (en) * 2003-05-14 2007-11-20 Wyeth Avian vaccine composition for the protection of poultry against disease and infection caused by E. coli and Salmonella
CN101575586B (zh) * 2009-05-31 2011-01-19 华中农业大学 一种支气管败血波氏杆菌基因缺失疫苗及应用
KR101321501B1 (ko) * 2011-09-21 2013-10-29 주식회사 바이오포아 조류 대장균증 백신 조성물 및 이의 제조방법
BRPI1105176A2 (pt) * 2011-11-22 2013-09-10 Unicamp linhagens de escherichia coli, atenuadas para septicemia em aves, vacinas produzidas com essas linhagensm, metodo de produÇço de vacinas e seus usos
US9814769B2 (en) 2014-09-30 2017-11-14 Qatar University Vaccines against pathogenic Escherichia coli and methods of using the same
CN106465698A (zh) * 2016-09-24 2017-03-01 王德 一种预防雏鸡大肠杆菌病的方法
CN106987549B (zh) * 2017-04-26 2020-08-21 河北科星药业有限公司 培养基及相应的预防禽类大肠杆菌病的广谱菌苗的生产方法
KR20190070457A (ko) 2017-12-13 2019-06-21 주식회사 오투파워 이산화염소를 포함하는 닭 대장균증 예방을 위한 음용수 첨가용 조성물
CN112442473B (zh) * 2020-12-02 2022-10-25 青岛易邦生物工程有限公司 一种禽大肠杆菌疫苗株
CN112494641B (zh) * 2020-12-02 2022-07-05 青岛易邦生物工程有限公司 一种禽大肠杆菌活疫苗
CN112695004A (zh) * 2020-12-28 2021-04-23 南通大学 APEC双基因rpoS和arcA缺失菌株及弱毒疫苗
EP4252770A1 (en) 2022-04-01 2023-10-04 Veterinärmedizinische Universität Wien Composition comprising irradiated e. coli
CN116024151B (zh) * 2022-12-13 2024-01-26 南通大学 一种禽致病性大肠杆菌sRNA s078基因缺失菌株及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0040958B1 (en) 1980-05-26 1984-03-14 Ici Australia Limited Process for the synthesis of gamma-unsaturated carboxylic acid esters
JPH085802B2 (ja) 1986-08-13 1996-01-24 日清製粉株式会社 家禽大腸菌症ワクチン
GB8912330D0 (en) 1989-05-30 1989-07-12 Wellcome Found Live vaccines
US5641491A (en) 1993-06-15 1997-06-24 The Penn State Research Foundation Escherichia coli strain 364 and use of said strain as a vaccine
JPH07206705A (ja) * 1993-11-03 1995-08-08 American Cyanamid Co 生インオボ(in ovo)ワクチン
TR199902522T2 (xx) * 1997-04-11 2000-04-21 B. Of S.Visors Of Louisiana State Uni. & Agricul.& Bal�k patojenlerine kar�� zay�flat�lm�� invazif a��.
GB9806449D0 (en) * 1998-03-25 1998-05-27 Peptide Therapeutics Ltd Attenuated bacteria useful in vaccines
US7297338B2 (en) * 2003-05-14 2007-11-20 Wyeth Avian vaccine composition for the protection of poultry against disease and infection caused by E. coli and Salmonella

Also Published As

Publication number Publication date
ATE380557T1 (de) 2007-12-15
DK1622642T3 (da) 2008-03-25
AU2004240584B2 (en) 2010-01-07
BE2012C053I2 (xx) 2023-08-09
CN100387299C (zh) 2008-05-14
SI1622642T1 (sl) 2008-04-30
KR101106024B1 (ko) 2012-01-17
EP1622642A1 (en) 2006-02-08
NZ543559A (en) 2008-02-29
DE602004010643D1 (de) 2008-01-24
JP2007500745A (ja) 2007-01-18
JP2011234721A (ja) 2011-11-24
EP1622642B1 (en) 2007-12-12
FR12C0073I2 (fr) 2013-08-16
PL1622642T3 (pl) 2008-03-31
BRPI0410332B1 (pt) 2019-10-08
PT1622642E (pt) 2008-02-18
AU2004240584A1 (en) 2004-12-02
ES2297448T3 (es) 2008-05-01
HK1083597A1 (en) 2006-07-07
HUS1200029I1 (hu) 2017-02-21
CA2524942C (en) 2012-10-23
DE602004010643T2 (de) 2008-12-04
ZA200509979B (en) 2008-11-26
BRPI0410332A (pt) 2006-05-30
MXPA05012218A (es) 2006-02-08
US7357935B2 (en) 2008-04-15
FR12C0073I1 (xx) 2013-01-18
US20040234534A1 (en) 2004-11-25
US7575754B2 (en) 2009-08-18
CO5640040A2 (es) 2006-05-31
CY1107188T1 (el) 2012-10-24
CA2524942A1 (en) 2004-12-02
US20080213317A1 (en) 2008-09-04
CN1822855A (zh) 2006-08-23
WO2004103402A1 (en) 2004-12-02
TW200505475A (en) 2005-02-16
AR044338A1 (es) 2005-09-07
KR20060012612A (ko) 2006-02-08
JP5334029B2 (ja) 2013-11-06

Similar Documents

Publication Publication Date Title
HRP20080069T3 (en) Avian e. coli vaccine for the protection against colibacillosis
NO20005224L (no) BTK inhibitorer og fremgangsmåter for deres identifikasjon og anvendelse
WO2001079463A3 (en) Nucleic acids encoding polypeptides having haloperoxidase activity
WO2005041653A3 (de) Synergistische fungizide wirkstoffkombinationen
DK1268431T3 (da) 3-Cyanoquinoliner, 3-cyano-1,6-naphthyridiner og 3-cyano-1,7-naphthyridiner som proteinkinaseinhibitorer
DE60007095D1 (de) Calanolide zur hemmung von btk
WO2004024757A3 (en) Modified pna molecules
MXPA02010068A (es) Derivados halogenados de acido-2-amino-5,6-heptenoico utiles como inhibidores de la oxido nitrico sintasa.
AU2001258316A1 (en) Process for the fermentative preparation of l-threonine
PL375255A1 (en) Prodrugs of proton pump inhibitors
AU2003244214A1 (en) Inducer, and inducer-equipped pump
WO2004108894A3 (en) Methods and compositions for amino acid production
WO2002075507A3 (en) Anti-bacterial vaccine compositions
HK1086548A1 (en) Deuterated catecholamine derivatives and medicaments comprising said compounds
EP1548107A4 (en) CHROMOPROTEIN AND FLUOROPROTEINS
BRPI0409521A (pt) uso do pentapeptìdeo iiaek, do pentapeptìdeo ipavf e/ou do hexapeptìdeo ipavfk, produto alimentìcio e processo para a preparação de um produto alimentìcio
PT1272652E (pt) Virus de herpes para a modulacao imunitaria
NZ511366A (en) Virulence genes and proteins, and their use
WO2001054707A3 (de) Veränderung von oberflächenproteomem durch aminopeptidase-inhibitoren
WO2003012115A3 (en) Dna molecules encoding herbicide tolerant acetolactate synthase
HK1080712A1 (en) Ihnv g protein for immune stimulation
FR2901137B1 (fr) Nouvelles formes galeniques d'inhibiteurs naturels des enzymes proteasiques, extraits d'oeuf de caille, associes a des vitamines ou/et a des mineraux, acides amines incorpores dans un excipient.
WO2005020954A3 (en) Proton pump inhibitor formulations, and methods of preparing and using such formulations
WO2003000930A3 (en) Nucleotide sequences involved in plant disease resistance
RS50355B (sr) Formulacije eritropoietina sa više doza